News | January 21, 2025
Moderna announces updates on pandemic influenza program
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
Increases speed to market for drug developers working on nucleic acid therapeutics
ICMR will continue to track trends in HMPV circulation throughout the year
Prithwish has close to 28 years of experience in a Commercial role
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program
Subscribe To Our Newsletter & Stay Updated
